 | Immutep (NASDAQ:IMMP) Stock Passes Below 50 Day Moving Average of $3.16
americanbankingnews.com - March 4 at 2:22 AM |
| Immutep (NASDAQ:IMMP) Trading 5.2% Higher
americanbankingnews.com - February 24 at 10:38 PM |
| Immutep (NASDAQ:IMMP) Trading Down 7%
americanbankingnews.com - February 22 at 9:20 PM |
| Immutep (NASDAQ:IMMP) Shares Cross Below 50 Day Moving Average of $3.25
americanbankingnews.com - February 19 at 4:20 AM |
| Short Interest in Immutep Limited (NASDAQ:IMMP) Declines By 72.6%
americanbankingnews.com - February 11 at 3:16 PM |
| Immutep (NASDAQ:IMMP) Shares Up 9.2%
americanbankingnews.com - February 9 at 7:40 PM |
 | Immutep's lead candidate efti moves forward in mid-stage COVID-19 study - Seeking Alpha
seekingalpha.com - January 27 at 6:07 PM |
 | Immutep Announces Advancement Of Phase II Trial For Eftilagimod Alpha In Covid-19 Patients To Randomised Portion Of The Study - GlobeNewswire
globenewswire.com - January 27 at 6:07 PM |
 | Form 6-K IMMUTEP Ltd For: Jan 22 - StreetInsider.com
streetinsider.com - January 25 at 1:17 PM |
| Immutep Limited (IMMP) Announces Licensing Partner GSK to Discontinue Ulcerative Colitis Phase II Clinical Trial Evaluating GSK2831781 - StreetInsider.com
streetinsider.com - January 25 at 8:16 AM |
|
 | With SPAC Deal Completed, Golden Nugget Online Gaming Stock Can Move Forward - Nasdaq
nasdaq.com - January 22 at 9:14 AM |
| Ulcerative Colitis Phase II Study of GSK2831781 Discontinued - GlobeNewswire
globenewswire.com - January 22 at 9:14 AM |
 | Toni Pearen recounts disturbing encounter with director as a young girl - Yahoo Finance Australia
au.finance.yahoo.com - January 21 at 11:42 PM |
| Immutep Quarterly Activities Report Nasdaq:IMMP - GlobeNewswire
globenewswire.com - January 21 at 11:42 PM |
| Ulcerative Colitis Phase II Study of GSK2831781 Discontinued
finance.yahoo.com - January 21 at 6:41 PM |
| Immutep Quarterly Activities Report
finance.yahoo.com - January 21 at 6:41 PM |
| Immutep Gets An Incomplete - Seeking Alpha
seekingalpha.com - January 19 at 6:01 PM |
| Immutep Completes Recruitment of Head and Neck Cancer Patients of Phase II TACTI-002 Study - Yahoo Finance
finance.yahoo.com - January 8 at 12:37 AM |
| Immutep Limited (IMMP) Reports Complete Recruitment of Head & Neck Cancer Patients of Phase II TACTI-002 Study - StreetInsider.com
streetinsider.com - January 7 at 2:34 PM |
| Immutep completes recruitment in efti mid-stage study in head & neck cancer - Seeking Alpha
seekingalpha.com - January 7 at 2:34 PM |
| Immutep Completes Recruitment of Head and Neck Cancer Patients of Phase II TACTI-002 Study - GlobeNewswire
globenewswire.com - January 6 at 11:32 PM |
| Immutep Limited (IMMP) Gains on US Patent Grant - StreetInsider.com
streetinsider.com - January 1 at 10:14 PM |
| The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data - Yahoo Finance
finance.yahoo.com - December 30 at 12:28 PM |
| Immutep Secures US Patent For Cancer Drug; Shares Jump 9.5% - Nasdaq
nasdaq.com - December 30 at 7:27 AM |
 | Why AVZ Minerals, Immutep, Kogan, & Strategic Elements shares are pushing higher - The Motley Fool Australia
fool.com.au - December 30 at 1:08 AM |
| Immutep Secures United States Patent For Eftilagimod Alpha In Combination With A PD-1 Pathway Inhibitor - GlobeNewswire
globenewswire.com - December 29 at 7:53 PM |
 | IMMP.O - Immutep Ltd Profile | Reuters
reuters.com - December 23 at 10:49 PM |
| Immutep (ASX:IMM) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway - Yahoo Finance
finance.yahoo.com - December 19 at 11:41 PM |
|
| Why the Immutep (ASX:IMM) share price is on watch today - The Motley Fool Australia
fool.com.au - December 16 at 7:21 PM |
| Immutep Upscales Efti Manufacturing Nasdaq:IMMP - GlobeNewswire
globenewswire.com - December 16 at 7:21 PM |
| Immutep Upscales Efti Manufacturing
finance.yahoo.com - December 16 at 9:07 AM |
| Immutep Operational Update - Yahoo Finance
finance.yahoo.com - December 15 at 2:10 PM |
| Immutep Operational Update
finance.yahoo.com - December 15 at 9:06 AM |
 | Arvinas News Alert: Why ARVN Stock Is Skyrocketing Today - InvestorPlace
investorplace.com - December 14 at 6:04 PM |
 | Silver Spike, Immutep, 8x8: 5 Top Stock Gainers for Thursday - TheStreet
thestreet.com - December 10 at 4:13 PM |
| ASX stock of the day: Immutep (ASX:IMM) shares blast up 60% on trial news - The Motley Fool Australia
fool.com.au - December 10 at 4:13 PM |
 | Why Greenwich LifeSciences, Immutep And Tenet Are Trading Higher Today - Benzinga
benzinga.com - December 10 at 4:13 PM |
| Immutep, Greenwich LifeSciences leads healthcare gainers; Xenetic Biosciences, Oncternal Therapeutics among major losers - Seeking Alpha
seekingalpha.com - December 10 at 4:13 PM |
| Analyzing The Price Action In Immutep Stock Today - Benzinga
benzinga.com - December 10 at 4:13 PM |
| Immutep's Chinese Partner EOC Pharma to Start Phase II Metastatic Breast Cancer Study - Benzinga
benzinga.com - December 9 at 6:10 PM |
| Immutep Reports Statistically Significant Survival Benefit for Key Patient Groups in the Ongoing Phase IIb AIPAC Study in Metastatic Breast Cancer - GlobeNewswire
globenewswire.com - December 9 at 6:10 PM |
| Immutep Reports Statistically Significant Survival Benefit for Key Patient Groups in the Ongoing Phase IIb AIPAC Study in Metastatic Breast Cancer
finance.yahoo.com - December 9 at 6:10 PM |
| Immutep’s Chinese Partner EOC Pharma to Start Phase II Metastatic Breast Cancer Study
finance.yahoo.com - December 9 at 6:10 PM |
| Immutep to enroll additional patients in mid-stage study with its lead cancer program - Seeking Alpha
seekingalpha.com - November 19 at 1:48 PM |
| Why a2 Milk, Crown, Immutep, & Suncorp shares are dropping lower - Motley Fool Australia
fool.com.au - November 19 at 3:47 AM |
| Immutep Completes a A$29.6 Million Placement to Accelerate and Broaden its Clinical Development - GlobeNewswire
globenewswire.com - November 19 at 3:47 AM |
| Immutep Completes a A$29.6 Million Placement to Accelerate and Broaden its Clinical Development - Yahoo Finance
finance.yahoo.com - November 18 at 10:32 PM |
| Immutep Announces Expansion of TACTI-002 Collaboration Trial - GlobeNewswire
globenewswire.com - November 18 at 10:32 PM |
| Immutep's Phase II TACTI-002 Study Reports Encouraging Data at SITC - GlobeNewswire
globenewswire.com - November 10 at 2:02 AM |
| Immutep rallies on Australian patent grant for IMP701 antibody
seekingalpha.com - November 9 at 9:01 PM |
